News and Announcements
Crowd Mobile to Raise $3 Million Via Placement & Rights Issue
- Published August 19, 2016 4:11PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
19th August 2016, ASX Announcement
Highlights:
- A$2.4 million raised through a share placement
- A$1.0 million Rights Issue which is partially underwritten
- Funds raised will support our ongoing marketing initiatives, investments in product development and earnings growth strategy.
Crowd Mobile Limited (ASX:CM8 & FWB-XETRA:CM3, Crowd Mobile, “the Company”) is pleased to announce that it has received commitments from sophisticated and professional investors to subscribe for A$2.4 million of new and fully paid ordinary shares in the Company at 16 cents per share with a 1 for 2 free attaching option exercisable at 27 cents, expiring 2 year from the date issue (“Share Placement”).
Crowd Mobile also announces a Non-Renounceable Rights Issue to raise A$1.0 million on the same terms as those of the Share Placement (“Rights Issue”). A$0.6 of the Rights Issue is being underwritten by DJ Carmichael Pty Limited (“DJC”), which combined with the Share Placement raises A$3.0 million in total.
To view the full announcement, please click on the button below.
Company Updates
122% Returns: The Aussie Crypto Fund Outperforming Bitcoin
In the ever-shifting world of cryptocurrency investments, one fund has made waves by consistently outperforming its peers. This fund has demonstrated a remarkable ability to navigate the volatility of the digital asset market while delivering impressive returns. By employing a combination of strategic risk management, selective investing, and benchmarking against Bitcoin, Merkle Tree Capital has […]
Empowering Global Trade: TradeWindow’s Innovative Approach
Dive into an exclusive interview with AJ Smith, Founder & CEO of TradeWindow, as he unveils how TradeWindow is empowering businesses with digital tools to navigate the complexities of global trade. From reducing costs to improving real-time visibility and collaboration, TradeWindow is at the forefront of driving productivity and digital adoption in international trade. Gain […]
Novapep’s Pioneering Approach to Treating Inflammatory Bowel Diseases
Join Jay Hennock, CEO of Novapep, as he unveils the company’s mission to address unmet medical needs through peptide-based therapies. Novapep, an Australian/US biotech, has developed a patented peptide structure called biparediteTM as an oral inflammatory bowel disease therapy, which will be a cost effective first-in-class drug. Biparetide has been shown in animals to be […]
Backed By Leading Investment Groups and Family Offices
